v3.25.3
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Sep. 30, 2025
Sep. 30, 2024
Income Statement [Abstract]        
Revenues $ 11,800 $ 233,600 $ 340,100 $ 357,700
Cost of goods sold 10,570 18,243 22,208 24,733
Gross profit 1,230 215,357 317,892 332,967
Operating Expenses:        
Research and development 2,594,750 1,453,363 7,467,532 5,004,794
General and administrative 1,115,491 1,048,987 4,672,192 4,193,225
Total Operating Expenses 3,710,241 2,502,350 12,139,724 9,198,019
Loss From Operations (3,709,011) (2,286,993) (11,821,832) (8,865,052)
Other (Expense) Income:        
Interest income 57,740 158,547 231,621 497,089
Other income 930 566 3,336 150,498
Gain on exchange of warrants 1,711,698
Change in fair value of warrant liabilities 612,064 1,036,464 552,536 (837,466)
Total Other Income 670,734 1,195,577 787,493 1,521,819
Net Loss $ (3,038,277) $ (1,091,416) $ (11,034,339) $ (7,343,233)
Net Loss Per Share - Basic $ (0.33) $ (0.13) $ (1.26) $ (0.96)
Net Loss Per Share - Diluted $ (0.33) $ (0.13) $ (1.26) $ (0.96)
Weighted Average Common Shares Outstanding - Basic 9,116,172 8,121,499 8,742,085 7,643,437
Weighted Average Common Shares Outstanding - Diluted 9,116,172 8,121,499 8,742,085 7,643,437

Source